Identification of Patients With High Probability of Not or Poorly Responding to Mycophenolate-mofetil (Cellcept) or Mycophenolate-natrium (Myfortic) Therapy.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Dec 2017
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Mycophenolate sodium (Primary)
- Indications Renal transplant rejection
- Focus Pharmacogenomic; Therapeutic Use
- 25 Dec 2017 Planned End Date changed from 1 Jun 2013 to 1 Dec 2018.
- 25 Dec 2017 Planned primary completion date changed from 1 Mar 2013 to 1 Dec 2018.
- 25 Dec 2017 Status changed from recruiting to active, no longer recruiting.